Background Fatty liver disease in the absence of excessive alcohol consumption is an
increasingly common condition with a global prevalence of~ 25–30% and is also associated …

Currently, steatohepatitis has been designated as metabolic dysfunction-associated
steatohepatitis (MASLD). MASLD risk factors mainly include metabolic disorders but can …

Abstract Purpose of Review The objective of this manuscript is to examine the current
literature on non-alcoholic fatty liver disease (NAFLD) biomarkers and their correlation with …

Background A new fatty liver disease nomenclature, steatotic liver disease (SLD) has been
proposed; however, there are no data on clinical outcomes. We investigated the impact of …

Background Metabolic-associated fatty liver disease (MAFLD), one of the most common liver
diseases, is detected in patients with concomitant hepatic steatosis and Type 2 Diabetes …

Methods This cross-sectional multicenter study was done in cohorts of subjects who
underwent a comprehensive medical health checkup between January 2014 and December …

Background and aims Chronic kidney disease (CKD) and non-alcoholic fatty liver disease
(NAFLD) share common risk factors and pathogenesis mechanisms. However, the …

Background/Aims We explored whether high sodium intake, assessed by urinary excretion,
determines the risk of sarcopenia and nonalcoholic fatty liver disease (NAFLD). Methods We …

Aim China has the highest rail transportation density in the world. Compared to other
occupational populations, railway workers in China face increased risk of chronic non …

This study examined the link between fatty liver disease (FLD) and cataracts, as previous
research has suggested that FLD may contribute to metabolic syndrome, systemic …